Clinical Studies on Itraconazole

Koji Takaki, Yoshiro Sawae, Kaoru Okada, Nobuyuki Shimono, Hiroyasu Misumi

研究成果: Contribution to journalArticle査読

1 被引用数 (Scopus)

抄録

We performed clinical studies on itraconazole, a new triazole antifungal agent. Four patients suffering from candidemia, pulmonary aspergillosis, oral thrush, and urinary tract infection due to Trichosporon cutaneum were treated with itraconazole at a single daily dose of 100-200 mg for 9-31 days. Clinical response was good in all patients. Bacteriological effect was eradicated in 2 cases, diminished in one and unknown in one. No side effect was observed and there were no abnormal laboratory findings. A suspected case of pulmonary cryptococcosis tolerated long-term administration of itraconazole at a daily dose of 100-150 mg for 198 days without observable adverse reactions.

本文言語英語
ページ(範囲)273-278
ページ数6
ジャーナルNippon Ishinkin Gakkai Zasshi
32
4
DOI
出版ステータス出版済み - 1991

All Science Journal Classification (ASJC) codes

  • 微生物学
  • 感染症

フィンガープリント

「Clinical Studies on Itraconazole」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル